These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19491656)

  • 21. Effects of morin on the pharmacokinetics of nicardipine after oral and intravenous administration of nicardipine in rats.
    Piao YJ; Choi JS
    J Pharm Pharmacol; 2008 May; 60(5):625-9. PubMed ID: 18416939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of green tea extract and (-)-epigallocatechin-3-gallate on pharmacokinetics of nadolol in rats.
    Misaka S; Miyazaki N; Fukushima T; Yamada S; Kimura J
    Phytomedicine; 2013 Nov; 20(14):1247-50. PubMed ID: 23920278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced oral bioavailability of docetaxel in rats by four consecutive days of pre-treatment with curcumin.
    Yan YD; Kim DH; Sung JH; Yong CS; Choi HG
    Int J Pharm; 2010 Oct; 399(1-2):116-20. PubMed ID: 20727390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liquid chromatography-mass spectrometry method for the quantification of tamoxifen and its metabolite 4-hydroxytamoxifen in rat plasma: application to interaction study with biochanin A (an isoflavone).
    Singh SP; Wahajuddin ; Ali MM; Kohli K; Jain GK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Oct; 879(27):2845-51. PubMed ID: 21890435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of genistein on the pharmacokinetics of paclitaxel administered orally or intravenously in rats.
    Li X; Choi JS
    Int J Pharm; 2007 Jun; 337(1-2):188-93. PubMed ID: 17267149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of silibinin, inhibitor of CYP3A4 and P-glycoprotein in vitro, on the pharmacokinetics of paclitaxel after oral and intravenous administration in rats.
    Lee CK; Choi JS
    Pharmacology; 2010; 85(6):350-6. PubMed ID: 20523105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.
    Chow HH; Cai Y; Alberts DS; Hakim I; Dorr R; Shahi F; Crowell JA; Yang CS; Hara Y
    Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):53-8. PubMed ID: 11205489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of quercetin on the pharmacokinetics of Etoposide after oral or intravenous administration of etoposide in rats.
    Li X; Choi JS
    Anticancer Res; 2009 Apr; 29(4):1411-5. PubMed ID: 19414395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of tamoxifen after intravenous and oral dosing of tamoxifen-hydroxybutenyl-beta-cyclodextrin formulations.
    Buchanan CM; Buchanan NL; Edgar KJ; Little JL; Malcolm MO; Ruble KM; Wacher VJ; Wempe MF
    J Pharm Sci; 2007 Mar; 96(3):644-60. PubMed ID: 17083091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered pharmacokinetics of paclitaxel by the concomitant use of morin in rats.
    Choi BC; Choi JS; Han HK
    Int J Pharm; 2006 Oct; 323(1-2):81-5. PubMed ID: 16806758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of the antioxidant baicalein on the pharmacokinetics of nimodipine in rats: a possible role of P-glycoprotein and CYP3A4 inhibition by baicalein.
    Cho YA; Choi JS; Burm JP
    Pharmacol Rep; 2011; 63(4):1066-73. PubMed ID: 22001996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of morin on the pharmacokinetics of etoposide in rats.
    Li X; Yun JK; Choi JS
    Biopharm Drug Dispos; 2007 Apr; 28(3):151-6. PubMed ID: 17315145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of ketoconazole on the intestinal metabolism, transport and oral bioavailability of K02, a novel vinylsulfone peptidomimetic cysteine protease inhibitor and a P450 3A, P-glycoprotein dual substrate, in male Sprague-Dawley rats.
    Zhang Y; Hsieh Y; Izumi T; Lin ET; Benet LZ
    J Pharmacol Exp Ther; 1998 Oct; 287(1):246-52. PubMed ID: 9765344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peracetylation as a means of enhancing in vitro bioactivity and bioavailability of epigallocatechin-3-gallate.
    Lambert JD; Sang S; Hong J; Kwon SJ; Lee MJ; Ho CT; Yang CS
    Drug Metab Dispos; 2006 Dec; 34(12):2111-6. PubMed ID: 16997910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of liver fibrosis on verapamil pharmacokinetics in rats.
    Chen M; Xu D; Hu XL; Wang H
    Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):287-94. PubMed ID: 17973928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of myricetin on the bioavailability of doxorubicin for oral drug delivery in rats: possible role of CYP3A4 and P-glycoprotein inhibition by myricetin.
    Choi SJ; Shin SC; Choi JS
    Arch Pharm Res; 2011 Feb; 34(2):309-15. PubMed ID: 21380815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of oral bioavailability of paclitaxel after oral administration of Schisandrol B in rats.
    Jin J; Bi H; Hu J; Zhong G; Zhao L; Huang Z; Huang M
    Biopharm Drug Dispos; 2010 May; 31(4):264-8. PubMed ID: 20437465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of an in vivo preclinical screen model to estimate absorption and first-pass hepatic extraction of xenobiotics. II. Use of ketoconazole to identify P-glycoprotein/CYP3A-limited bioavailability in the monkey.
    Ward KW; Stelman GJ; Morgan JA; Zeigler KS; Azzarano LM; Kehler JR; McSurdy-Freed JE; Proksch JW; Smith BR
    Drug Metab Dispos; 2004 Feb; 32(2):172-7. PubMed ID: 14744938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism.
    Lau YY; Okochi H; Huang Y; Benet LZ
    Drug Metab Dispos; 2006 Jul; 34(7):1175-81. PubMed ID: 16624870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and P-gp inhibition by quercetin.
    Choi JS; Piao YJ; Kang KW
    Arch Pharm Res; 2011 Apr; 34(4):607-13. PubMed ID: 21544726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.